[Yonhap News] Upcoming Seminar on January 24, 2024: “Changes brought about by Chrome’s Third-Party Cookie Ban”
Yonhap News reported on January 18, 2024, about a seminar featuring Attorney Hwan Kyoung Ko, scheduled for January 24, 2024. The event, titled "Changes brought about by Chrome's Third-Party Cookie Ban: New Challenges and Data Strategies for the Online Media Industry", is hosted by the Digital Communication Research Center (DCRC) at Konkuk University and supported by the Google News Initiative. The seminar will feature a keynote speech by Mr. Ko titled "Implications of Strengthening Privacy Laws for the News Industry." This presentation will focus on explaining the changes in the legal landscape behind Chrome's third-party cookie ban and offer insights into how the online media sector, including news organizations, can adapt to an increasingly privacy-aware landscape.
[Law Times] AI in Everyday Life and the Implications of the U.S. AI Executive Order – Hwan Kyoung KO, Lee & Ko
On January 18, 2024, an article by Attorney Hwan Kyoung KO was published in the Law Times. In the article, Mr. KO explains in detail the key elements of the U.S. AI Executive Order and states that “Based on this, I hope to see a display of leadership that further refines the Digital Bill of Rights and spearheads discussions on the establishment of global standards”.
[Joseilbo-Tax Daily] Lee&Ko Global Commerce Institute (GCI) Publishes an Issue Brief on “7 Major Global Economic and Trade Issues and the Response Strategy”
9 Jan 2024. The Joseilbo featured the new of Lee&Ko Global Commerce Institute (GCI)’s issue brief publication. Lee&Ko GCI anticipated in the “7 Major Global Economic and Trade Issues and the Response Strategy in 2024” issue brief (Volume 1, 2024) that the direction of global macroeconomic indicators for this year will be volatile. Additionally, it highlighted the escalating competition between the U.S. and China, the increasing geopolitical uncertainty, the expansion of factors disrupting global supply chains, and the anticipated worldwide spread of protectionist trade policies based on national priorities.
[Chosun Biz][Law Firm Practice Skills] Lee & Ko Protects Boryung Pharmaceutical’s Right in Hypertension Treatment with KRW 50 Billion in Sales
On January 8, 2024, Chosun Biz reported Lee & Ko’s recent win for Boryung Pharmaceutical, noting that “as the efficacy of Dukarb®, Boryung’s hypertension drug, went viral, it became the target of other Korean pharmaceutical companies” but “Boryung has defended its Dukarb® patent all the way from the Intellectual Property Trial and Appeal Board stage to the ensuing trials, with Lee & Ko’s Healthcare Practice Group, led by Ms. Keum Nang Park, playing a key role in the defense.” Ms. Park remarked in an interview that “this is the first time a Korean pharmaceutical company that has developed an original drug defended its patent rights in a large-scale dispute against multiple generic companies,” further noting that “we felt that this drug should be afforded patent protection especially since it was a new drug developed after many challenges in Korea, where new drug R&D is still rare.”